Renalcellekarcinom og venøs tumortrombe

Jakob Mejdahl Bentin; Imran Jamal Iversen; Lisbeth Bredahl Rosengaard; Jens Juel Thiis; Per Bagi

doi:10.61409/V06230354

Renalcellekarcinom og venøs tumortrombe

Jakob Mejdahl Bentin, Imran Jamal Iversen, Lisbeth Bredahl Rosengaard, Jens Juel Thiis, Per Bagi

1 Citationer (Scopus)

Abstract

Renal cell carcinomas (RCCs) represent 2-3% of cancer cases in Denmark, with increasing incidence. RCCs invading the inferior vena cava (IVC) with tumour thrombus (TT) are associated with poor prognosis. Classification is based on tumour extent in the IVC. Surgical treatment involves radical nephrectomy and thrombectomy, with different approaches depending on TT level. Complications are significant, with a mortality rate of 2-13%. Additional therapies may improve outcomes. This review finds that all patients with RCC and IVC TT should be considered for surgery.

Bidragets oversatte titel	Renal cell carcinoma and venous tumour thrombus
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	186
Udgave nummer	1
ISSN	0041-5782
DOI	https://doi.org/10.61409/V06230354
Status	Udgivet - 1 jan. 2024

Emneord

Carcinoma, Renal Cell/diagnosis
Humans
Kidney Neoplasms/surgery
Nephrectomy/adverse effects
Retrospective Studies
Thrombectomy
Thrombosis
Vena Cava, Inferior/surgery

Adgang til dokumentet

10.61409/V06230354

Andre filer og links

https://ugeskriftet.dk/videnskab/renalcellekarcinom-og-venos-tumortrombe

Citationsformater

@article{5b1ff1b1125e4f4fbe884516a37064d8,

title = "Renalcellekarcinom og ven{\o}s tumortrombe",

abstract = "Renal cell carcinomas (RCCs) represent 2-3% of cancer cases in Denmark, with increasing incidence. RCCs invading the inferior vena cava (IVC) with tumour thrombus (TT) are associated with poor prognosis. Classification is based on tumour extent in the IVC. Surgical treatment involves radical nephrectomy and thrombectomy, with different approaches depending on TT level. Complications are significant, with a mortality rate of 2-13%. Additional therapies may improve outcomes. This review finds that all patients with RCC and IVC TT should be considered for surgery.",

keywords = "Carcinoma, Renal Cell/diagnosis, Humans, Kidney Neoplasms/surgery, Nephrectomy/adverse effects, Retrospective Studies, Thrombectomy, Thrombosis, Vena Cava, Inferior/surgery",

author = "Bentin, {Jakob Mejdahl} and Iversen, {Imran Jamal} and Rosengaard, {Lisbeth Bredahl} and Thiis, {Jens Juel} and Per Bagi",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2024",

month = jan,

day = "1",

doi = "10.61409/V06230354",

language = "Dansk",

volume = "186",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "1",

}

TY - JOUR

T1 - Renalcellekarcinom og venøs tumortrombe

AU - Bentin, Jakob Mejdahl

AU - Iversen, Imran Jamal

AU - Rosengaard, Lisbeth Bredahl

AU - Thiis, Jens Juel

AU - Bagi, Per

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2024/1/1

Y1 - 2024/1/1

N2 - Renal cell carcinomas (RCCs) represent 2-3% of cancer cases in Denmark, with increasing incidence. RCCs invading the inferior vena cava (IVC) with tumour thrombus (TT) are associated with poor prognosis. Classification is based on tumour extent in the IVC. Surgical treatment involves radical nephrectomy and thrombectomy, with different approaches depending on TT level. Complications are significant, with a mortality rate of 2-13%. Additional therapies may improve outcomes. This review finds that all patients with RCC and IVC TT should be considered for surgery.

AB - Renal cell carcinomas (RCCs) represent 2-3% of cancer cases in Denmark, with increasing incidence. RCCs invading the inferior vena cava (IVC) with tumour thrombus (TT) are associated with poor prognosis. Classification is based on tumour extent in the IVC. Surgical treatment involves radical nephrectomy and thrombectomy, with different approaches depending on TT level. Complications are significant, with a mortality rate of 2-13%. Additional therapies may improve outcomes. This review finds that all patients with RCC and IVC TT should be considered for surgery.

KW - Carcinoma, Renal Cell/diagnosis

KW - Humans

KW - Kidney Neoplasms/surgery

KW - Nephrectomy/adverse effects

KW - Retrospective Studies

KW - Thrombectomy

KW - Thrombosis

KW - Vena Cava, Inferior/surgery

UR - https://ugeskriftet.dk/videnskab/renalcellekarcinom-og-venos-tumortrombe

U2 - 10.61409/V06230354

DO - 10.61409/V06230354

M3 - Review

C2 - 38235778

SN - 0041-5782

VL - 186

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 1

ER -

Renalcellekarcinom og venøs tumortrombe

Abstract

Emneord

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater